We are monitoring the impact of COVID-19 & Recession alarm on Europe Gene Therapy Market Get in touch with us for detailed analysis Know More

Know More

Share on

Europe Gene Therapy Market Research Report - Segmented By Vector Type, Application and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Size, Share, Trends, COVID-19 Impact & Forecast (2022 to 2027)

Published: January, 2022
ID: 11531
Pages: 90

Europe Gene Therapy Market Size (2022 to 2027)

The European Gene Therapy Market size is estimated to be growing at a CAGR of 24.6% between 2022 to 2027.

The European gene therapy market is expected to be driven by the factors such as the growing incidence of cancer, other target diseases, and growing new pipeline developments for gene therapy. Gene therapies have brought a revolutionary change in the field of health science and pharmaceuticals. Rising government support and financing activities for improved healthcare facilities in developed countries such as Germany, the United Kingdom, France, and Italy and increased research and development activities by researchers and industry players are projected to further propel the gene therapy market. The active participation of major industry players has resulted in adopting strategies such as productivity growth and product launch to strengthen their presence in the European regional market. Accelerating clinical trials, introducing new drugs to the market, partnerships, and product creation positively impact market growth in European countries.

Gene therapy includes repairing, repressing, or replacing dysfunctional genes that cause disease to re-establish normal function as it is influencing the market growth. Financial-based agreements and health outcomes-based agreements have been proposed or implemented to improve therapy accessibility and market survival. These models have significantly impacted the adoption of therapies in the market. However, European biopharmaceutical firms have taken several steps to achieve a strategic advantage. Companies use various market penetration techniques, such as expanding biopharmaceutical facilities, collaborating with other primary partners, and collaborating with Contract Manufacturing Organizations (CMOs).

Progress in current R&D has been sluggish as several universities have shut down and suspended all non-essential testing and enrollment procedures for clinical trials. The high cost of gene therapy, on the other hand, is likely to restrict market growth to a certain extent during the projected period. Stringent government regulations by the government in European countries on the gene therapy market are considered the major growth decline factor for market growth.

Impact of COVID-19 on the European Gene Therapy Market:

The European cell and gene therapy market has been affected by COVID-19. The majority of the raw materials required for cell and gene therapy can't get to the factories due to the ban on transportation. Patients and volunteers for cell therapy cannot visit hospitals, limiting the market for cell and gene therapy in Europe. The gene therapy sector's research and clinical growth, and industrial activities have been disrupted. Gene therapy research has remained relatively unaffected at the end of the forecast period. However, the market is anticipated to witness significant growth in the coming years. 

This research report on the European Gene Therapy Market has been segmented & sub-segmented into the following categories:

 By Vector Type:

  • Viral vector
    • Retroviruses
    • Lentiviruses
    • Adenoviruses
    • Adeno-associated Virus
    • Herpes Simplex Virus
    • Poxvirus
    • Vaccinia Virus
    • Others
  • Non-viral vector
    • Naked/Plasmid Vectors
    • Gene Gun
    • Electroporation
    • Lipofection
    • Others

By Application:

  • Oncological Disorders
  • Rare Diseases
  • Cardiovascular Diseases
  • Neurological Disorders
  • Infectious disease
  • Other Diseases

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

The Gene therapy market has witnessed significant growth in Europe over the years, and it is expected to have a promising growth rate during the forecast period. It increases healthcare expenditures, and introducing emerging technology in health care drives demand growth in this region. Hospitals are growing at a significant rate due to the increasing target population in Europe. In Europe, the United Kingdom gene therapy market had the largest share in 2020 and is expected to grow at a robust CAGR during the forecast period. In the health sciences and pharmaceutical sectors, gene therapy is seen as a future breakthrough. Despite the limited number of drugs that have made it to market, the number of clinical trials investigating gene therapy is rising in Europe. Delivering cell and gene therapies necessitates specialist equipment, capabilities, and clinician expertise. Cell and gene therapies can cure various severe disorders that aren't treatable by traditional approaches, fuelling the country's market growth.

The German gene therapy market is growing at a notable CAGR for a couple of years and is projected to share lucrative growth to the European market. Due to the expanded target population, provision of reimbursements, and novel payment solutions for cell and gene therapies in Germany, the Country accounted for the largest share of the European cell and gene therapy market, accounting for more than 20%.

KEY MARKET PLAYERS:

Some of the noteworthy companies operating in the European gene therapy market analyzed in this report are Biogen, Sarepta Therapeutics, Gilead Sciences, Inc., Amgen, Inc., Novartis AG, Orchard Therapeutics Plc, Spark Therapeutics, Inc., Molmed S.P.A., Anges, Inc., Bluebird Bio, Inc., Jazz Pharmaceuticals Plc, Dynavax Technologies, Human Stem Cells Institute, Sibiono Genetech Co., Ltd., Shanghai Sunway Biotech Co., Ltd., Uniqure N.V., Gensight Biologics S.A., Celgene Corporation, Cellectis, Sangamo Therapeutics, Mustang Bio, Applied Genetic Technologies Corporation and Poseida Therapeutics, Inc.

  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities       
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking                    
      1. Market share analysis      
      2. Products/Service
      3. Regional Presence               
    2. Mergers & Acquisition Landscape                     
    3. Joint Ventures & Collaborations
  6. MARKET SEGMENTATION
    1. By Vector Type
      1. Viral vector
        1. Retroviruses
        2. Lentiviruses
        3. Adenoviruses
        4. Adeno-associated Virus
        5. Herpes Simplex Virus
        6. Poxvirus
        7. Vaccinia Virus
        8. Others
      2. Non-viral vector
        1. Naked/Plasmid Vectors
        2. Gene Gun
        3. Electroporation
        4. Lipofection
        5. Others
      3. Y-o-Y Growth Analysis, By Vector Type
      4. Market Attractiveness Analysis, By Vector Type
      5. Market Share Analysis, By Vector Type
    2. By Application
      1. Oncological Disorders
      2. Rare Diseases
      3. Cardiovascular Diseases
      4. Neurological Disorders
      5. Infectious disease
      6. Other Diseases
      7. Y-o-Y Growth Analysis, By Application
      8. Market Attractiveness Analysis, By Application
      9. Market Share Analysis, By Application
  7. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. Europe
      1. Introduction
      2. U.K
      3. Spain
      4. Germany
      5. Italy
      6. France
      7. Rest of Europe
  8. STRATEGIC ANALYSIS
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  9. MARKET LEADERS' ANALYSIS
    1. Biogen
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Sarepta Therapeutics
    3. Gilead Sciences, Inc.
    4. Amgen, Inc.
    5. Novartis AG
    6. Orchard Therapeutics Plc
    7. Spark Therapeutics, Inc.
    8. Molmed S.P.A.
    9. Anges, Inc.
    10. Bluebird Bio, Inc.
    11. Jazz Pharmaceuticals Plc
    12. Dynavax Technologies
    13. Human Stem Cells Institute
    14. Sibiono Genetech Co., Ltd.
    15. Shanghai Sunway Biotech Co., Ltd.
    16. Uniqure N.V.
    17. Gensight Biologics S.A.
    18. Celgene Corporation
    19. Cellectis
    20. Sangamo Therapeutics
    21. Mustang Bio
    22. Applied Genetic Technologies Corporation
    23. Poseida Therapeutics, Inc.
  10. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  11. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  12. APPENDIX
  13. List of Tables
  14. List of Figures
  1. Europe Gene Therapy Market, By Vector Type, From 2022 - 2027 (USD Million)
  2. Europe Viral vector Market, By Region, From 2022 - 2027 (USD Million)
  3. Europe Non-viral vector Market, By Region, From 2022 - 2027 (USD Million)
  4. Europe Gene Therapy Market, By Application, From 2022 - 2027 (USD Million)
  5. Europe Oncological Disorders Market, By Region, From 2022 - 2027 (USD Million)
  6. Europe Rare Diseases Market, By Region, From 2022 - 2027 (USD Million)
  7. Europe Cardiovascular Diseases Market, By Region, From 2022 - 2027 (USD Million)
  8. Europe Neurological Disorders Market, By Region, From 2022 - 2027 (USD Million)
  9. Europe Infectious disease Market, By Region, From 2022 - 2027 (USD Million)
  10. Europe Other Diseases Market, By Region, From 2022 - 2027 (USD Million)
  11. U.K. Gene Therapy Market, By Vector Type, From 2022 - 2027 (USD Million)
  12. U.K. Gene Therapy Market, By Application, From 2022 - 2027 (USD Million)
  13. Germany Gene Therapy Market, By Vector Type, From 2022 - 2027 (USD Million)
  14. Germany Gene Therapy Market, By Application, From 2022 - 2027 (USD Million)
  15. France Gene Therapy Market, By Vector Type, From 2022 - 2027 (USD Million)
  16. France Gene Therapy Market, By Application, From 2022 - 2027 (USD Million)
  17. Italy Gene Therapy Market, By Vector Type, From 2022 - 2027 (USD Million)
  18. Italy Gene Therapy Market, By Application, From 2022 - 2027 (USD Million)
  19. Spain Gene Therapy Market, By Vector Type, From 2022 - 2027 (USD Million)
  20. Spain Gene Therapy Market, By Application, From 2022 - 2027 (USD Million)
  21. Europe Gene Therapy Market, By Viral vector, From 2022 - 2027 (USD Million)
  22. Europe Retroviruses Market, By Region, From 2022 - 2027 (USD Million)
  23. Europe Lentiviruses Market, By Region, From 2022 - 2027 (USD Million)
  24. Europe Adenoviruses Market, By Region, From 2022 - 2027 (USD Million)
  25. Europe Adeno-associated Virus Market, By Region, From 2022 - 2027 (USD Million)
  26. Europe Herpes Simplex Virus Market, By Region, From 2022 - 2027 (USD Million)
  27. Europe Poxvirus Market, By Region, From 2022 - 2027 (USD Million)
  28. Europe Vaccinia Virus Market, By Region, From 2022 - 2027 (USD Million)
  29. U.K. Gene Therapy Market, By Viral vector, From 2022 - 2027 (USD Million)
  30. Germany Gene Therapy Market, By Viral vector, From 2022 - 2027 (USD Million)
  31. France Gene Therapy Market, By Viral vector, From 2022 - 2027 (USD Million)
  32. Italy Gene Therapy Market, By Viral vector, From 2022 - 2027 (USD Million)
  33. Spain Gene Therapy Market, By Viral vector, From 2022 - 2027 (USD Million)
  34. Europe Gene Therapy Market, By Non-viral vector, From 2022 - 2027 (USD Million)
  35. Europe Naked/Plasmid Vectors Market, By Region, From 2022 - 2027 (USD Million)
  36. Europe Gene Gun Market, By Region, From 2022 - 2027 (USD Million)
  37. Europe Electroporation Market, By Region, From 2022 - 2027 (USD Million)
  38. Europe Lipofection Market, By Region, From 2022 - 2027 (USD Million)
  39. Europe Others Market, By Region, From 2022 - 2027 (USD Million)
  40. U.K. Gene Therapy Market, By Non-viral vector, From 2022 - 2027 (USD Million)
  41. Germany Gene Therapy Market, By Non-viral vector, From 2022 - 2027 (USD Million)
  42. France Gene Therapy Market, By Non-viral vector, From 2022 - 2027 (USD Million)
  43. Italy Gene Therapy Market, By Non-viral vector, From 2022 - 2027 (USD Million)
  44. Spain Gene Therapy Market, By Non-viral vector, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample